Tower Research Capital (TRC)’s Strata Skin Sciences SSKN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,292
| Closed | -$5.41K | – | 5541 |
|
|
2025
Q4 | $5.41K | Buy |
4,292
+2,463
| +135% | +$3.88K | ﹤0.01% | 4127 |
|
|
2025
Q3 | $3.77K | Sell |
1,829
-12,912
| -88% | -$25.6K | ﹤0.01% | 4453 |
|
|
2025
Q2 | $33.8K | Buy |
14,741
+12,963
| +729% | +$32.4K | ﹤0.01% | 3315 |
|
|
2025
Q1 | $4.69K | Buy |
1,778
+189
| +12% | +$527 | ﹤0.01% | 4211 |
|
|
2024
Q4 | $4.62K | Sell |
1,589
-179
| -10% | -$534 | ﹤0.01% | 4432 |
|
|
2024
Q3 | $4.86K | Buy |
1,768
+276
| +18% | +$862 | ﹤0.01% | 4398 |
|
|
2024
Q2 | $4.58K | Buy |
1,492
+297
| +25% | +$1.21K | ﹤0.01% | 4765 |
|
|
2024
Q1 | $4.52K | Buy |
1,195
+115
| +11% | +$600 | ﹤0.01% | 4669 |
|
|
2023
Q4 | $5.94K | Buy |
1,080
+566
| +110% | +$2.94K | ﹤0.01% | 4790 |
|
|
2023
Q3 | $3.06K | Sell |
514
-566
| -52% | -$4.35K | ﹤0.01% | 5060 |
|
|
2023
Q2 | $10.3K | Sell |
1,080
-35
| -3% | -$345 | ﹤0.01% | 4142 |
|
|
2023
Q1 | $12K | Sell |
1,115
-80
| -7% | -$804 | ﹤0.01% | 4123 |
|
|
2022
Q4 | $9K | Buy |
1,195
+414
| +53% | +$3.55K | ﹤0.01% | 4266 |
|
|
2022
Q3 | $7K | Buy |
781
+245
| +46% | +$2.49K | ﹤0.01% | 4928 |
|
|
2022
Q2 | $5K | Sell |
536
-669
| -56% | -$7.94K | ﹤0.01% | 5098 |
|
|
2022
Q1 | $18K | Buy |
1,205
+149
| +14% | +$2.22K | ﹤0.01% | 3646 |
|
|
2021
Q4 | $16K | Buy |
1,056
+635
| +151% | +$10.5K | ﹤0.01% | 3935 |
|
|
2021
Q3 | $8K | Buy |
421
+384
| +1,038% | +$5.86K | ﹤0.01% | 4567 |
|
|
2021
Q2 | $1K | Sell |
37
-882
| -96% | -$13.7K | ﹤0.01% | 5260 |
|
|
2021
Q1 | $15K | Buy |
919
+122
| +15% | +$2.21K | ﹤0.01% | 4119 |
|
|
2020
Q4 | $12K | Buy |
797
+94
| +13% | +$1.35K | ﹤0.01% | 4215 |
|
|
2020
Q3 | $9K | Buy |
703
+205
| +41% | +$2.83K | ﹤0.01% | 4156 |
|
|
2020
Q2 | $5K | Buy |
+498
| New | +$5.91K | ﹤0.01% | 4297 |
|
|
2020
Q1 | – | Sell |
-348
| Closed | -$7K | – | 3845 |
|
|
2019
Q4 | $7K | Sell |
348
-310
| -47% | -$7.04K | ﹤0.01% | 2546 |
|
|
2019
Q3 | $15K | Buy |
658
+474
| +258% | +$11.1K | ﹤0.01% | 2677 |
|
|
2019
Q2 | $5K | Buy |
+184
| New | +$4.59K | ﹤0.01% | 2962 |
|
|
2016
Q1 | – | Sell |
-44
| Closed | -$3K | – | 4883 |
|
|
2015
Q4 | $3K | Buy |
44
+34
| +340% | +$1.94K | ﹤0.01% | 3507 |
|
|
2015
Q3 | $1K | Buy |
+10
| New | +$579 | ﹤0.01% | 3672 |
|
|
2015
Q1 | – | Sell |
-16
| Closed | -$1K | – | 4903 |
|
|
2014
Q4 | $1K | Buy |
16
+2
| +14% | +$164 | ﹤0.01% | 3716 |
|
|
2014
Q3 | $1K | Buy |
+14
| New | +$1.64K | ﹤0.01% | 4149 |
|
Tower Research Capital (TRC)'s SSKN Position: Q1 2026 in Review
Tower Research Capital (TRC) sold out of Strata Skin Sciences (SSKN) in Q1 2026, closing a stake of 4,292 shares — an estimated $5.41K sold.
Tower Research Capital (TRC) first reported a position in SSKN in Q3 2014 and held it in 30 quarters. The position peaked at $33.8K in Q2 2025. 0 funds tracked by Wall St. Rank hold SSKN as of Q1 2026.
- Tower Research Capital (TRC) reported no remaining Strata Skin Sciences position as of Q1 2026 after selling out during the quarter.
- Tower Research Capital (TRC) sold 4,292 Strata Skin Sciences shares in Q1 2026, an estimated $5.41K.
- Tower Research Capital (TRC) first reported a position in Strata Skin Sciences in Q3 2014 and held it in 30 quarters.
- Tower Research Capital (TRC)'s Strata Skin Sciences position peaked at $33.8K in Q2 2025.
- 0 funds tracked by Wall St. Rank held Strata Skin Sciences as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.